Pfizer CEO Albert Bourla said on Monday that the development of a retooled Omicron vaccine specifically targeted to the newest coronavirus variant is the “most likely scenario” in the future fight against the disease. Making his remarks at the J.P. Morgan Healthcare Conference on Monday, Bourla said Pfizer and the German firm BioNTech SE are […] Read the full story on GreekReporter.com.
 |
| READ THE ORIGINAL POST AT greekreporter.com |
